In a July 28, 2026 statement, Rosie O'Donnell said a GLP-1 medication "saved my life" by quieting the constant thoughts about food she described as "food noise" that had plagued her for decades. The remarks offer a personal account of the drug's effect on her longstanding struggle.
Rosie O'Donnell stated on July 28, 2026 that a GLP-1 medication saved her life after it quieted the "food noise" she said she had battled for decades. The statement, which she released publicly, credits the drug with ending a persistent internal struggle she had experienced for many years.
O'Donnell explicitly said the GLP-1 drug "saved my life." She attributed that outcome to the drug's ability to silence the constant thoughts about food that she referred to as "food noise." According to her statement, this noise had been a presence in her life for decades before she used the medication.
In her statement, O'Donnell detailed that the "food noise" she battled for decades was a persistent, intrusive preoccupation with food. The GLP-1 drug reportedly stopped that mental chatter. She described this change as directly life-saving, highlighting the profound personal impact of the treatment.
O'Donnell did not specify which particular GLP-1 drug she used, nor did she provide additional details about her health history beyond the decades-long struggle with food noise. The statement stands as a personal testimony to the drug's effect on her quality of life. She credited the medication alone for the positive outcome.
The statement was made public on July 28, 2026. O'Donnell made no other claims about the drug's broader effects or its use by others. Her remarks focus solely on her own experience with the GLP-1 medication and how it quieted the food noise she had fought for decades, which she said saved her life.
Peptides referenced: GLP-1.
Related reading: GLP-1s in IBD: Study Raises Doubts About Newer Drugs, Altimmune's GLP-1/GIP Drug Pemvidutide Cuts Heavy Drinking Days in Mid-Stage Trial, Firefly Neuroscience and Next Health Form Partnership for Cognitive Platform, Prior GLP-1 RA Exposure Linked to Lower Septic Shock Mortality.